Physician profile
Michael S Bailey
NPI 1184663445
$2,152.11
in general payments reported to CMS, 2019-2025
11 companies · $21.82 in 2025
The $21.82 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $174 · 2022: $771 · 2023: $1,089 · 2024: $95.87 · 2025: $21.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $907 · Education: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.43 |
| Education | $298.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $941.89 | 2022-2023 | Adcetris |
| Pharmacyclics LLC, An Abbvie Company | $260.14 | 2022-2023 | Imbruvica |
| Daiichi Sankyo INC. | $250.00 | 2022-2023 | Enhertu |
| Incyte Corporation | $174.39 | 2021 | |
| Scilex Pharmaceuticals INC. | $131.30 | 2023-2024 | Ztlido |
| Abbvie INC. | $118.07 | 2023 | |
| Janssen Biotech, INC. | $111.44 | 2022 | |
| Biogen, INC. | $60.00 | 2022 | |
| Abbott Laboratories | $56.46 | 2023-2024 | Proclaim |
| Astellas Pharma US INC | $26.60 | 2024 | Padcev |
| Tersera Therapeutics LLC | $21.82 | 2025 | Zoladex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.